Oral appliance (OA) therapy has demonstrated efficacy in treating obstructive sleep apnea (OSA). The aim of this systematic review was to clarify the efficacy of device designs (Mono-block or Bi-block) in OA therapy for OSA patients. We performed a meta-analysis using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system. Two studies (Mono-block OA versus Bi-block OA) remained eligible after applying the exclusion criteria. When comparing Mono-block OA and Bi-block OA, Mono-block OA significantly reduced the apnea-hypopnea index (2.92; 95% confidence interval (95%CI), 1.26 to 4.58; 0.0006), and patient preference for Mono-block OA was significantly higher (2.06; 95%CI, 1.44 to 2.06; < 0.0001). Lowest SpO, arousal index, non-REM stage 3, sleep efficiency, Epworth Sleepiness Scale (ESS), Snoring Scale, and side effects were not significantly different between the two groups (lowest SpO: -11.18; 95%CI, -26.90 to 4.54; = 0.16, arousal index: 4.40; 95%CI, -6.00 to 14.80; = 0.41, non-REM stage 3: -2.00; 95%CI, -6.00 to 14.80; = 0.41, sleep efficiency: -1.42, 95%CI, -4.71 to 1.86; = 0.40, ESS: 0.12; 95%CI, -1.55 to 1.79; = 0.89, Snoring Scale: 0.55; 95%CI, -0.73 to 1.83, = 0.55, side effects: 1.00, 95%CI, 0.62 to 1.61, = 1.00). In this systematic review, the use of Mono-block OA was more effective than Bi-block OA for OSA patients.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747445 | PMC |
http://dx.doi.org/10.3390/ijerph16173182 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!